Worrisome news from Mexico: Drug resistance and DNA fingerprinting

International Journal of Tuberculosis and Lung Disease

Volumn 5, Issue 4, 2001, Pages 299-300

  Burman, W J ^a  

^a DENVER PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; DISEASE TRANSMISSION; DNA FINGERPRINTING; EDITORIAL; INCIDENCE; MEXICO; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; STATISTICS; TREATMENT FAILURE; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE; FEMALE; GENETICS, POPULATION; HUMANS; INCIDENCE; MALE; MEXICO; RISK ASSESSMENT; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0035042652     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico
2. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques
3. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico
4. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997
5. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis
6. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment outcomes in 6 countries
7. The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing
8. Tuberculosis epidemiology and control in Veracruz, Mexico